Printer Friendly
The Free Library
14,528,975 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Meditech Pharmaceuticals Inc., dated June 15, 2001.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-


Published Date:   June 15, 2001

Company Name:     Meditech Pharmaceuticals Inc.

Address:          10474 North 97th Street
                  Scottsdale, AZ 85258

Main Telephone
 Number:          480/614-2874

Internet Home
 Page Address
  (URL):          www.mdch.net

Chief Executive
 Officer:         Gerald Kern

Chief Financial
 Officer:         Steven Kern

Investor Relations
 Contact:         Steven Kern
 Business number: 310/441-1221
 E-mail address:  stevenikern@mdch.net

Public Relations
 Contact:         Steven Kern
 Business number: 310/441-1221
 E-mail address:  pr@mdch.net

Industry:         Biotech

Trading Symbol/
 Exchange:        OTCBB: MDCH


Company description: The company has developed new drugs for use against a wide variety of human viruses. One of its drugs has been tested and proved useful in reducing the size of tumors, another has proven effective against HSV-1 and 2, Epstein Barr Virus and Cytomegalovirus cytomegalovirus (sī'təmĕg'əlōvī`rəs), member of the herpesvirus family that can cause serious complications in persons with weakened immune systems. . A third is in advanced testing against Citrus Canker citrus canker
n.
A destructive bacterial disease of citrus plants that attacks seedlings and mature plants and causes defoliation and death.
, a plant disease which is devastating dev·as·tate  
tr.v. dev·as·tat·ed, dev·as·tat·ing, dev·as·tates
1. To lay waste; destroy.

2. To overwhelm; confound; stun: was devastated by the rude remark.
 to all types of citrus trees.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 15, 2001
Words:187
Previous Article:Corporate Profile for Dyax Corporation, dated June 15, 2001.
Next Article:Ebus Delivers Electric Shuttle Buses to the City of Anaheim; Ten All-Electric Vehicles Will Shuttle Hotel Guests at The Anaheim Resort.



Related Articles
Meditech Adds New Members to Advisory Board -- Immune Network Ltd. Exercises Option to Purchase Meditech Shares.
Immune Network Exercises Option on Meditech Pharmaceutical Stock.
Meditech Will Refile SB-2 Registration Statement.
Meditech and Immune Network Finalize Agreement.
Meditech to Begin Clinical Trials on Cold Sore - HSV - Compound, Adds New Member of Scientific Advisory Board.
Meditech's Announces Appointment of New President; Publication Date for Herpes Study Results Announced.
Progress Report on Meditech Cold Sore --HSV-1-- Clinical Trials.
Health care. (Newsmakers).(Brief Article)
MEDITECH/ELAN BIO VENTURE TO DEVELOP DISEASE SCANNERS.
Anthrax/Smallpox Scanners to be Showcased; Meditech Pharmaceuticals and Elan Bio to Demonstrate Scanner at BIO 2003.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles